Screening for hepatocellular carcinoma by Egyptian physicians

Table 7 Relation between medical specialty and knowledge about screening modalities, educational resources and guideline

	Specialty A		Specialty B		P value
	n	%	n	%
Most important screening for HCC					0.154
Physical examination	2	2	1	4
Alpha fetoprotein	28	21	8	33
Ultrasound	82	63	15	63
CT	18	14	0	0
2nd most important screening for HCC					0.238
Physical examination	2	2	0	0
Alpha fetoprotein	64	49	7	29
Ultrasound	16	12	5	21
CT	47	36	11	46
Angiography	1	1	1	4
3rd most important screening for HCC					0.383
Physical examination	3	2	2	9
Alpha fetoprotein	27	21	7	29
Ultrasound	16	12	1	4
CT	61	47	12	50
Angiography	10	8	1	4
Laparoscopy	13	10	1	4
Screening interval for high risk group					0.010a
Every 3 mo	85	65	9	38
6 mo or more	45	35	15	62
HBV treatment reduces HCC incidence					0.139
Yes	107	82	16	67
No	23	18	8	33
Guidelines in management of HCC					0.991
Yes	76	58	14	58
No	54	42	10	42
HCV RNA/ALT risk factors for HCC					0.147
Yes	75	58	10	42
No	55	42	14	58

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus; CT: Computer tomography.